Microglial interaction with β-amyloid: Implications for the pathogenesis of Alzheimer's disease

Microscopy Research and Technique

Volumn 54, Issue 2, 2001, Pages 59-70

  Bamberger, Maria E ^a   Landreth, Gary E ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's Disease; Beta amyloid; Inflammation; Microglia; Neurotoxicity; NSAIDs; Receptors; Signal transduction

Indexed keywords

BACTERIOPHAGES; CELL MEMBRANES; CHEMICAL ACTIVATION; GENE EXPRESSION; GLYCOPROTEINS; MOLECULES; NEURODEGENERATIVE DISEASES; PATIENT TREATMENT; TOXICITY;

ALZHEIMERS DISEASE; BETA AMYLOIDS; DIVERSE RANGE; ELEVATED LEVEL; INFLAMMATION; MICROGLIA; NEUROTOXICITY; NSAID; PROINFLAMMATORY MOLECULES; RECEPTOR;

SIGNAL TRANSDUCTION;

ACUTE PHASE PROTEIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CD45 ANTIGEN; CELECOXIB; CHEMOKINE; COMPLEMENT; CYTOKINE; GLUCOCORTICOID; IBUPROFEN; INTEGRIN; INTEGRIN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SCAVENGER RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; INFLAMMATION; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 0035879373     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1121     Document Type: Article

References (143)

1. Abraham CR, Selkoe DJ, Potter H. 1988. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501.
2. Adams JC. 1997. Thrombospondin-1. Int J Biochem Cell Biol 29:861-865.
3. Akiyama H, McGeer PL. 1990. Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30:81-93.
4. Akiyama H, Kawamata T, Yamada T, Tooyama I, Ishii T, McGeer PL. 1993. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol 85:628-634.
5. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
6. Antic A, Dzenko KA, Pachter JS. 2000. Engagement of the scavenger receptor is not responsible for beta-amyloid stimulation of monocytes to a neurocytopathic state. Exp Neurol 161:96-101.
7. Araujo DM, Cotman CW. 1992. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569:141-145.
8. Baldwin AS Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683.
9. Bamberger ME, Harris ME, Landreth GE. 2000. Identification of fibrillar amyloid receptors on microglial cells. 2000 Soc for Neurosci Abstract, Vol. 26, p 2047.
10. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Leiberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916-919.
11. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Yolk B, Berger M. 1991. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285:111-114.
12. Benveniste EN. 1992. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263:C1-16.
13. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM. 1990. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 30:201-212.
14. Benzing WC, Wujek JR, Ward EK, Shatter D, Ashe KH, Younkin SG, Brunden KR. 1999. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20:581-589.
15. Bianca VD, Dusi S, Bianchini E, Dal Pra I, Rossi F. 1999. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274:15493-15499.
16. Boland K, Behrens M, Choi D, Manias K, Perlmutter DH. 1996. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. J Biol Chem 271:18032-18044.
17. Bornstein P. 1995. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130:503-506.
18. Bradt BM, Kolb WP, Cooper NR. 1998. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med 188:431-438.
19. Breitner JC. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47:401-411.
20. Brown E, Hooper L, Ho T, Gresham H. 1990. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111:2785-2794.
21. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. 1999. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 54:M357-364.
22. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237-239.
23. Chao CC, Hu S, Kravitz FH, Tsang M, Anderson WR, Peterson PK 1994. Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol Chem Neuropathol 23: 159-178.
24. Chen LM, Bailey D, Fernandez-Valle C. 2000. Association of beta 1 integrin with focal adhesion kinase and paxillin in differentiating Schwann cells. J Neurosci 20:3776-3784.
25. Chen S, Frederickson RC, Brunden KR. 1996. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches. Neurobiol Aging 17: 781-787.
26. Christie RH, Freeman M, Hyman BT. 1996. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol 148:399-403.
27. Chung KC, Park JH, Kim CH, Ahn YS. 1999. Tumor necrosis factor-alpha and phorbol 12-myristate 13-acetate differentially modulate cytotoxic effect of nitric oxide generated by serum deprivation in neuronal PC12 cells. J Neurochem 72:1482-1488.
28. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
29. Combs CK, Johnson DJ, Cannady SB, Lehman TM, Landreth GE. 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins. J Neurosci 19:928-939.
30. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 20:558-567.
31. Combs CK, Karlo JC, Kao S-C, Landreth GE. 2001. Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci, 21:1179-1188.
32. Coria F, Castano E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, Frangione B. 1988. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 58:454-458.
33. Crowley M, Harmer S, DeFranco A. 1996. Activation-induced association of a 145kDa tyrosine phosphorylated protein with Shc and Syk in B-lymphocytes and macrophages. J Biol Chem 271:1145-1152.
34. Dawson CH, Brown BL, Dobson PR. 1997. A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. Biochem Biophys Res Commun 233: 279-282.
35. Delhase M, Hayakawa M, Chen Y, Karin M. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation [see comments]. Science 284:309-313.
36. DeWitt DA, Perry G, Cohen M, Doller C, Silver J. 1998. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 149:329-340.
37. Downen M, Amaral TD, Hua LL, Zhao ML, Lee SC. 1999. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28:114-127.
38. Duong T, Nikolaeva M, Acton PJ. 1997. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease. Brain Res 749:152-156.
39. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. 1996. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382:716-719.
40. Emmerling MR, Spiegel K, Watson MD. 1997. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide. Immunopharmacology 38:101-109.
41. Emmerling MR, Watson MD, Raby CA, Spiegel K. 2000. The role of complement in Alzheimer's disease pathology. Biochim Biophys Acta 1502:158-171.
42. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, Silverstein RL. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274:19055-19062.
43. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr, Hajjar DP, Nicholson AC. 2000. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 41:688-696.
44. Fiala M, Zhang L, Gan X, Sherry B, Taub D, Graves MC, Hama S, Way D, Weinand M, Witte M, Lorton D, Kuo YM, Roher AE. 1998. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 4:480-489.
45. Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G. 1991. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett 129:318-320.
46. Finkelstein LD, Shimizu Y. 2000. Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the alpha4beta1 integrin to mitogen-activated protein kinase signalling. Biochem J 345 Pt 2:385-392.
47. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM. 1998. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152:307-317.
48. Frohman EM, Frohman TC, Gupta S, de Fougerolles A, van den Noort S. 1991. Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J Neurol Sci 106:105-111.
49. Ganter U, Strauss S, Jonas U, Weidemann A, Beyreuther K, Volk B, Berger M, Bauer J. 1991. Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein. FEBS Lett 282:127-131.
50. Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA. 1996a. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J Cell Biol 135:533-544.
51. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. 1996b. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 271:21-24.
52. Gazizadeh S, Bolen JB, Fleit HB. 1994. Physical and functional association of Src-related protein tyrosine kinases with Fc gamma RII in monocytic THP-1 cells. J Biol Chem 269:8878-8884.
53. Ghiso J, Rostagno A, Gardella JE, Liem L, Gorevic PD, Frangione B. 1992. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J 288:1053-1059.
54. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo LM, Roher AE. 1996. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021-6037.
55. Goldstein JL, Ho YK, Basu SK, Brown MS. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76:333-337.
56. Gollin PA, Kalaria RN, Eikelenboom P, Rozemuller A, Perry G. 1992. Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport 3:201-203.
57. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. 1996. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149:21-28.
58. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CLd, Araoz C. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611-7615.
59. Haga S, Ikeda K, Sato M, Ishii T. 1993. Synthetic Alzheimer amyloid beta/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res 601:88-94.
60. Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM Jr, Nicholson AC. 2000, Transforming growth factor-betal (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem 275: 1241-1246.
61. Hartung HP, Kladetzky RG, Melnik B, Hennerici M. 1986. Stimulation of the scavenger receptor on monocytes-macrophages evokes release of arachidonic acid metabolites and reduced oxygen species. Lab Invest 55:209-216.
62. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, Klockgether T. 1998. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem 71:88-94.
63. Heneka MT, Klockgether T, Feinstein DL. 2000. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 20:6862-6867.
64. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94:1500-1505.
65. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158:2882-2890.
66. Huang F, Buttini M, Wyss-Coray T, McConlogue L, Kodama T, Pitas RE, Mucke L. 1999. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am J Pathol 155:1741-1747.
67. Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin J, Smith C, Beckman J. 1992. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298:431-437.
68. Ishii K, Muelhauser F, Liebl U, Picard M, Kuhl S, Penke B, Bayer T, Wiessler M, Hennerici M, Beyreuther K, Hartmann T, Fassbender K. 2000. Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase. Faseb J 14:1485-1489.
69. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T. 1997. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51:135-138.
70. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. 1989. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol 24:173-182.
71. Iwamoto N, Nishiyama E, Ohwada J, Arai H. 1994. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 177:23-26.
72. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10.
73. Jiang C, Ting AT, Seed B. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
74. Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ. 1994. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 152:5050-5059.
75. Jiang P, Lagenaur CF, Narayanan V. 1999. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem 274:559-562.
76. Kalaria RN. 1999. Microglia and Alzheimer's Disease. Curr Opin Hematol 6:15-24.
77. Klegeris A, McGeer PL. 1997. beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 49:229-235.
78. Klegeris A, Walker DG, McGeer PL. 1994. Activation of macrophages by Alzheimer beta amyloid peptide. Biochem Biophys Res Commun 199:984-991.
79. Klegeris A, Walker DG, McGeer PL. 1997. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha. Brain Res 747:114-121.
80. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637.
81. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150: 2659-2667.
82. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. 1997. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
83. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM. 2000. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714.
84. Lin TH, Yurochko A, Kornberg L, Morris J, Walker JJ, Haskill S, Juliano RL. 1994. The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes. J Cell Biol 126: 1585-1593.
85. Lin TH, Rosales C, Mondal K, Bolen JB, Haskill S, Juliano RL. 1995. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem 270:16189-16197.
86. Lindberg FP, Gresham HD, Schwarz E, Brown EJ. 1993. Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol 123:485-496.
87. Liu Y, Dargusch R, Schubert D. 1997. Beta amyloid toxicity does not require RAGE protein. Biochem Biophys Res Commun 237:37-40.
88. Lorton D, Kocsis JM, King L, Madden K, Brunden KR. 1996. beta-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J Neuroimmunol 67: 21-29.
89. Mackenzie IR, Munoz DG. 1998. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50: 986-990.
90. Marcilla A, Rivero-Lezcano OM, Agarwal A, Robbins KC. 1995. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fcγ receptors. J Biol Chem 270:9115-9120.
91. Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, Saitoh T. 1991. Immunoreactivity of CD45 a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol 83:12-20.
92. Matter ML, Zhang Z, Nordstedt C, Ruoslahti E. 1998. The alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis. J Cell Biol 141:1019-1030.
93. 2. J Exp Med 188:2257-2265.
94. McDonald DR, Brunden KR, Landreth GE. 1997. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci 17:2284-2294.
95. McDonald D, Bamberger M, Combs C, Landreth G. 1998. β-amyloid fibril activate parallel mitogen-activated protein kinase pathways in microglia and THP-1 monocytes. J Neurosci 18:4451-4460.
96. McGilvray ID, Lu Z, Bitar R, Dackiw APB, Davreux CJ, Rotstein OD. 1997. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J Biol Chem 272:10287-10294.
97. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374:647-650.
98. Meda L, Bernasconi S, Bonaiuto C, Sozzani S, Zhou D, Otvos L Jr, Mantovani A, Rossi F, Cassatella MA. 1996. Beta-amyloid (25-35) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J Immunol 157:1213-1218.
99. Meda L, Baron P, Prat E, Scarpini E, Scarlato G, Cassatella MA, Rossi F. 1999. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol 93:45-52.
100. Mehlhorn G, Hollborn M, Schliebs R. 2000. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with alzheimer pathology. Int J Dev Neurosci 18:423-431.
101. Meng F, Lowell CA. 1998. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. Embo J 17:4391-4403.
102. Mi ZP, Jiang P, Weng WL, Lindberg FP, Narayanan V, Lagenaur CF. 2000. Expression of a synapse-associated membrane protein, P84/ SHPS-1, and its ligand, IAP/CD47, in mouse retina. J Comp Neurol 416:335-344.
103. Morino N, Mimura T, Hamasaki K, Tobe K, Ueki K, Kikuchi K, Takehara K, Kadowaki T, Yazaki Y, Nojima Y. 1995. Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2. J Biol Chem 270:269-273.
104. Murphy GM Jr, Yang L, Cordell B. 1998. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J Biol Chem 273:20967-20971.
105. Netland EE, Newton JL, Majocha RE, Tate BA. 1998. Indomethacin reverses the microglial response to amyloid beta-protein. Neurobiol Aging 19:201-204.
106. Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP. 2000. CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci 902:128-131.
107. Ogura T, Tatemichi M, Esumi H. 1997. TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochem Biophys Res Commun 233:788-791.
108. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17:553-565.
109. Pasinetti GM, Aisen PS. 1998. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324.
110. Peress NS, Fleit HB, Perillo E, Kuljis R, Pezzullo C. 1993. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J Neuroimmunol 48:71-79.
111. Perlmutter LS, Barron E, Chui HC. 1990. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 119:32-36.
112. Rath PC, Aggarwal BB. 1999. TNF-induced signaling in apoptosis. J Clin Immunol 19:350-364.
113. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. 1995. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-55.
114. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
115. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I. 1992. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 89:10016-10020.
116. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGeer P. 1996. Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 17:681-686.
117. Rossi F, Bianchini E. 1996. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem Biophys Res Commun 225:474-478.
118. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 1997. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68: 2092-2097.
119. Scharnagl H, Tisljar U, Winkler K, Huttinger M, Nauck MA, Gross W, Wieland H, Ohm TG, Marz W. 1999. The betaA4 amyloid peptide complexes to and enhances the uptake of beta- very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway. Lab Invest 79:1271-1286.
120. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. 1999. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
121. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. 1990. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144:129-135.
122. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. 1997. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657.
123. Stewart WF, Kawas C, Corrada M, Metter EJ. 1997. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
124. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. 1992. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66:223-230.
125. Streit WJ, Kincaid-Colton CA. 1995. The brain's immune system. Sci Am 273:54-55 58-61.
126. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Wandel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
127. Tan J, Town T, Mori T, Wu Y, Saxe M, Crawford F, Mullan M. 2000. CD45 opposes beta -amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci 20:7587-7594.
128. Tarkowski E, Blennow K, Wallin A, Tarkowski A. 1999. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19:223-230.
129. Thery C, Stanley ER, Mallat M. 1992. Interleukin 1 and tumor necrosis factor-alpha stimulate the production of colony-stimulating factor 1 by murine astrocytes. J Neurochem 59:1183-1186.
130. Van Muiswinkel FL, Veerhuis R, Eikelenboom P. 1996. Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 66:2468-2476.
131. Van Muiswinkel FL, Raupp SF, de Vos NM, Smits HA, Verhoef J, Eikelenboom P, Nottet HS. 1999. The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages. J Neuroimmunol 96:121-130.
132. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. 1999. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A 96:9879-9884.
133. Viviani B, Corsini E, Galli CL, Marinovich M. 1998. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 150:271-276.
134. Wang XQ, Frazier WA. 1998. The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells. Mol Biol Cell 9:865-874.
135. Watson DJ, Lander AD, Selkoe DJ. 1997. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. J Biol Chem 272: 31617-31624.
136. Webster S, Bonnell B, Rogers J. 1997. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Am J Pathol 150:1531-1536.
137. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, Esler WP, Maggio JE, Mantyh PW. 1998. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 18:2161-2173.
138. Wood JG, Zinsmeister P. 1991. Tyrosine phosphorylation systems in Alzheimer's disease pathology. Neurosci Lett 121:12-16.
139. Xia M, Qin S, McNamara M, Mackay C, Hyman BT. 1997. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150:1267-1274.
140. Xia MQ, Qin SX, Wu LJ, Mackay CR, Hyman BT. 1998. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 153:31-37.
141. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen S, Stern D. 1994. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A 91:7787-7791.
142. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. 1996. RAGE and amyloid-beta peptide neuroloxicity in Alzheimer's disease. Nature 382:685-691.
143. Yates SL, Burgess LH, Kocsis-Angle J, Antal JM, Dority MD, Embury PB, Piotrkowski AM, Brunden KR. 2000. Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J Neurochem 74:1017-1025.